Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
PI3K/AKT/PTEN pathway as a target for Crohn’s disease therapy (Review) | International Journal of Molecular Medicine |
| 61 | 2014 |
Advances in medical therapy of inflammatory bowel disease | Current Opinion in Pharmacology |
| 3 | 2005 |
10.1097/MOG.0000000000000077 | ||||
The JAK2 variant rs10758669 in Crohn’s disease: altering the intestinal barrier as one mechanism of action | International Journal of Colorectal Disease |
| 36 | 2011 |
Genetics and pathogenesis of inflammatory bowel disease | Nature |
| 1,691 | 2011 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
The prophylaxis functions of Lactobacillus fermentumGLF‐217 and Lactobacillus plantarumFLP‐215 on ulcerative colitis via modulating gut microbiota of mice | Journal of the Science of Food and Agriculture |
| 2024 | |
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients | Indian Journal of Gastroenterology |
| 2 | 2024 |
Ameliorative effect of an acidic polysaccharide from Phellinus linteus on ulcerative colitis in a DSS-induced mouse model | International Journal of Biological Macromolecules |
| 2024 | |
Metabolic Nanoregulator Remodels Gut Microenvironment for Treatment of Inflammatory Bowel Disease | ACS Nano |
| 2024 | |
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials | Expert Review of Gastroenterology & Hepatology |
| 2024 |